March 9, 2026
Innovation and collaboration at Euro-BioImaging’s AMMI Maastricht Node
Euro-BioImaging’s Advanced Microscopy and Molecular Imaging (AMMI) Node is a single-sited mixed Node centrally located in Maastricht,…
March 9, 2026
Euro-BioImaging’s Advanced Microscopy and Molecular Imaging (AMMI) Node is a single-sited mixed Node centrally located in Maastricht,…
March 3, 2026
This review article by Lucien Hinderling and colleagues of the Euro-BioImaging Smart Microscopy Working Group, published in Methods in Microscopy in…
March 2, 2026
Are you a Euro-BioImaging Node staff member eager to broaden your professional horizons, exchange innovative ideas, and enhance your expertise? The third and…
February 24, 2026
Euro-BioImaging has officially kicked off the second edition of the EVOLVE Mentoring Programme, welcoming 17 mentoring pairs from 16 countries and 4 companies…
February 24, 2026
Need to look at the biomechanical properties of a sample? IPHYS Bioimaging Facility, part of Euro-BioImaging’s Advanced…
February 13, 2026
Bugra Oezdemir, our image data tools specialist from the Euro-BioImaging Bio-Hub team, had the pleasure of co-leading a session at the Data Science…
February 12, 2026
The IIS La Fe (Instituto de Investigación Sanitaria La Fe) in Valencia, hosting the Euro-BioImaging Radiology and Medical Imaging Valencia Node, has…
February 11, 2026
Today is the International Day of Women and Girls in Science. And tomorrow. And the day after that. The images below show our…
February 10, 2026
Registration is now officially open for the 2026 Image Data Community Days! The Image data community days are an annual online gathering engaging…
February 9, 2026
In this edition of our Meet the Nodes interview series, we introduce Irma Mahmutovic Persson, staff researcher at the Lund BioImaging Centre…
February 3, 2026
There’s a new marine sample dataset on the BioImage Archive, thanks to Tina Wiegand and her colleagues,…
February 3, 2026
Breast cancer remains one of the most common cancers worldwide, and HER2-positive tumours — characterised by overexpression of the HER2 receptor — are…